Manpreet K. Chawla

Manpreet Chawla practices at Rothman Orthopaedic Specialty Hospital in Bensalem, Pennsylvania, part of Thomas Jefferson University.

Manpreet Chawla's NPI, 1891002143, was assigned on September 8, 2010. Manpreet Chawla holds Pennsylvania license MD446727.

Manpreet Chawla's primary practice is Rothman Orthopaedic Specialty Hospital, at 3300 Tillman Drive, Bensalem, PA 19020 in Bucks County. The practice phone is (215) 244-7400.

Manpreet Chawla's primary practice is Rothman Orthopaedic Specialty Hospital in Bensalem, Pennsylvania, part of Thomas Jefferson University. Manpreet Chawla is also affiliated with Jefferson Torresdale Hospital. The medical group on file is Chawla Consultants. Dmand AI also links Manpreet Chawla to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Manpreet Chawla practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Manpreet Chawla's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Manpreet Chawla's licenses on file in 2 states: Pennsylvania and New Hampshire.

CMS data shows 774 Medicare services from Manpreet Chawla across 3 procedure codes in 2024, for 627 Medicare patients. Medicare paid $84,011 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 627 Medicare patients who saw Manpreet Chawla in 2024. The largest group is 65 to 74, with 373 patients. 75% of them have arthritis, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Manpreet Chawla's median patient age at 67, with 56% women.

In 2024, Manpreet Chawla wrote 19 Medicare Part D claims. 89% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $56 in total drug cost. In 2018, CMS named 138 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Manpreet Chawla for performance year 2024, reported individually. Manpreet Chawla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Manpreet Chawla from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Amneal Pharmaceuticals LLC paid the most, $234.